Suppr超能文献

泪囊移行细胞癌的外科治疗:是否需要新的治疗方案?

Surgical management of transitional cell carcinoma of the lacrimal sac: Is it time for a new treatment algorithm?

机构信息

Department of General Surgery, The Royal Wolverhampton Hospital, New Cross, Wolverhampton UK.

出版信息

J Plast Reconstr Aesthet Surg. 2012 Feb;65(2):e33-6. doi: 10.1016/j.bjps.2011.09.029. Epub 2011 Oct 8.

Abstract

Transitional cell carcinoma (TCC) arising in the lacrimal sac is a rare neoplasm. Despite radical surgery and radiotherapy, these tumors generally have a poor prognosis due to an often late diagnosis, high rate of loco-regional recurrence and mortality. There are only a relatively small number of documented cases of TCC when compared to other epithelial malignancies of the lacrimal drainage system. As would be anticipated, there are currently no evidence-based clinical practice guidelines for the treatment of these lesions. We present an illustrative case and consider the literature in relation to current surgical management of these tumors. We propose an alternate management consideration for these tumors.

摘要

泪囊部的移行细胞癌(TCC)是一种罕见的肿瘤。尽管进行了根治性手术和放疗,但由于常常诊断较晚、局部复发率和死亡率高,这些肿瘤的预后通常较差。与泪液排出系统的其他上皮恶性肿瘤相比,TCC 的病例相对较少。可以预料的是,目前尚无针对这些病变的循证临床实践指南。我们提供了一个说明性病例,并结合文献讨论了这些肿瘤的当前手术治疗方法。我们提出了一种针对这些肿瘤的替代治疗方案。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验